Abbott has also received the "Vietnam - Best Place to Work 2022" award, which honors its diverse and innovative working environment where employees are cared for and given the opportunity to change people's lives for the better.

These latest commitments in India and the award in Vietnam, where Abbott has been operating for 28 years, along with its technology breakthroughs which have won global recognition, are all dedicated to addressing healthcare challenges and serving people in more than 160 countries to lead healthier, better lives.

Tasked with bringing innovations to people

In its 2030 Sustainability Plan, Abbott has identified specific strategic actions to advance healthcare and transform its business, aiming to extend the reach of innovation to more than 3 billion people globally. The action plan includes building an innovative workforce, creating a resilient supply chain, modernizing the healthcare system, protecting the environment, and improving human health.

By the end of 2021, the company's technologies and products, which cover a wide range of healthcare from nutrition and pharmaceuticals to diagnostics and medical devices, had helped improve the lives of 2.2 billion people worldwide.

Abbott's innovations provide timely and scientifically accurate information to help doctors and professionals make the right decisions, thereby improving treatment efficiency. For example, Abbott's FreeStyle Libre, the world's leading wearable glucose monitoring sensor-based technology, is a revolutionary innovation that detects not only current glucose levels but also provides retrospective information to help patients adjust their lifestyle and help healthcare professionals make better treatment decisions and reduce the risks of diabetes complications.

{ "id": "4SfST2m_SE", "type": "myToolImages", "data": { "data": "" } }

The FreeStyle Libre system, launched in Vietnam in March 2021, has transformed diabetes management and treatment efficiency for over 4.5 million people around the world. It received the "Best Medical Technology" of the last 50 years at the Prix Galien Golden Jubilee Awards, one of Abbott's 11 Prix Galien Awards.

In helping treat premature and newborn babies with patent ductus arteriosus (PDA), a heart defect that can develop soon after birth, Abbott has the Amplatzer Piccolo Occluder, a pea-sized device that helps doctors repair holes in the tiny hearts of premature and infants weighing as little as 700 grams (about 1.5 pounds) without riskier surgery. The technology is now available in Vietnam.

{ "id": "Jww4f_jzVS", "type": "myToolImages", "data": { "data": "" } }

Abbott has received the prestigious recognition as the 2020 World Changing Company of the Year by Fast Company, a title to honor the company's innovative efforts to improve lives.

When COVID-19 broke out, within just months, Abbott developed a comprehensive portfolio of COVID-19 tests to confront the virus in different ways. It formed the Abbott Pandemic Defense Coalition, a first-of-its-kind global scientific network dedicated to identifying new viral threats, taking quick action when one is discovered, and helping prevent future pandemics.

{ "id": "0uzzlojNv5", "type": "myToolImages", "data": { "data": "" } }

{ "id": "tN5vw44u5X", "type": "myToolImages", "data": { "data": "" } }

{ "id": "dPZyfR5KUa", "type": "myToolImages", "data": { "data": "" } }

This is an important part of Abbott's work to create new technologies to detect, monitor and transform the care of infectious diseases such as COVID-19, HIV, malaria, and hepatitis, as well as future pandemic threats.

For a healthy and sustainable Vietnam

Since 1995, Abbott has continuously brought comprehensive healthcare technology solutions and products to Vietnam.

It has also worked alongside the government, partners, and stakeholders to advance health equity and address health disparities, particularly in malnutrition and chronic diseases.

Since 2006, Abbott has partnered with Americares and Giao Diem Humanitarian Foundation to enhance nutrition for children, primarily in the central provinces of Quang Tri and Thua Thien-Hue, where child malnutrition rates are among the highest in the country. The program provides training courses, food processing equipment, medical diagnostic tools, and educational materials. Abbott also offers PediaSure, a clinically proven nutrition solution to help promote catch-up growth and unlock growth potential in children at nutritional risk.

Malnutrition among children under five in Viet Nam has steadily decreased. The Millennium development goal of reducing malnutrition rates to below 20 per cent by 2015 was achieved seven years ahead of schedule, in 2008.

Abbott has partnered with the Vietnam Women's Union for over a decade to promote the benefits of breast milk and breastfeeding, and to expand healthcare and nutrition education across the country. The program raises public awareness about healthcare to ensure that Vietnamese people know how to promote healthy pregnancies and breastfeeding, improve the well-being of women and children, and establish family health.

To date, Abbott and the Abbott Foundation have invested nearly VND280 billion in Viet Nam to help address critical health issues, with a focus on advancing, preventing, and treating chronic diseases, training medical professionals, and raising public awareness about healthcare.

"With almost three decades of Abbott in Viet Nam, we sustain our long-term partnership programs to tackle healthcare challenges and remove barriers in malnutrition and chronic diseases," said Douglas Kuo, Divisional Vice President and General Manager of Abbott in Vietnam.

"With sustainability at the forefront, we work together to change people's lives for the better, for a healthier and stronger Viet Nam."